Nom du produit:2-{6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}benzoic acid

IUPAC Name:2-{6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}benzoic acid

CAS:1423029-05-3
Formule moléculaire:C13H10N4O2
Pureté:95%+
Numéro de catalogue:CM412143
Poids moléculaire:254.25

Unité d'emballage Stock disponible Prix($) Quantité
CM412143-250mg 3-4 Weeks ŽǎŁ
CM412143-500mg 4-5 Weeks ijřƏ
CM412143-1g 4-5 Weeks ħţǟ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1423029-05-3
Formule moléculaire:C13H10N4O2
Point de fusion:-
Code SMILES:CC1=NN2C(C=C1)=NN=C2C1=C(C=CC=C1)C(O)=O
Densité:
Numéro de catalogue:CM412143
Poids moléculaire:254.25
Point d'ébullition:
N° Mdl:MFCD17593704
Stockage:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

Related Products